Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Acetazolamide in Acute Decompensated Heart Failure
NCT06475105Phase 4Recruiting
- Sponsor
- Diponegoro University
- Start
- Apr 2024
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in heart failure (HF) comparing Oral Acetazolamide with Placebo (2 arms). Primary endpoint: Successful Decongestion at 3 days. Started Apr 2024; status: recruiting.
02
Drugs
acetazolamide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT06475105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06475105.